{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:12:34Z","timestamp":1788909154386,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,9]]},"DOI":"10.7759\/cureus.87583","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T11:55:23Z","timestamp":1752062123000},"source":"Crossref","is-referenced-by-count":2,"title":["The Temporal Trends and Attributed Risk Burden of Kidney Cancer, Bladder Cancer, and Prostate Cancer in China From 1990 to 2021"],"prefix":"10.7759","author":[{"given":"Feng","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfei","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuguang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-024-00569-w","article-title":"Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021","volume":"11","author":"Zi H","year":"2024","unstructured":"Zi H, Liu MY, Luo LS, et al.. Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Mil Med Res. 2024, 11:64. 10.1186\/s40779-024-00569-w","journal-title":"Mil Med Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-022-00406-y","article-title":"Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition)","volume":"9","author":"Jin YH","year":"2022","unstructured":"Jin YH, Zeng XT, Liu TZ, et al.. Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition). Mil Med Res. 2022, 9:44. 10.1186\/s40779-022-00406-y","journal-title":"Mil Med Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","author":"Ferlay J","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, Bray F. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021, 10.1002\/ijc.33588","journal-title":"Int J Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1062504","article-title":"Burden of kidney cancer and attributed risk factors in China from 1990 to 2019","volume":"10","author":"Wang Z","year":"2022","unstructured":"Wang Z, Wang L, Wang S, Xie L. Burden of kidney cancer and attributed risk factors in China from 1990 to 2019. Front Public Health. 2022, 10:1062504. 10.3389\/fpubh.2022.1062504","journal-title":"Front Public Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-19909-5","article-title":"The disease burden of bladder cancer and its attributable risk factors in five Eastern Asian countries, 1990-2019: a population-based comparative study","volume":"24","author":"Luo LS","year":"2024","unstructured":"Luo LS, Luan HH, Zhang P, Jiang JF, Zeng XT, Huang J, Jin YH. The disease burden of bladder cancer and its attributable risk factors in five Eastern Asian countries, 1990-2019: a population-based comparative study. BMC Public Health. 2024, 24:2404. 10.1186\/s12889-024-19909-5","journal-title":"BMC Public Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol31090408","article-title":"Exploring prostate cancer incidence trends and age change in cancer registration areas of Jiangsu Province, China, 2009 to 2019","volume":"31","author":"Zhou H","year":"2024","unstructured":"Zhou H, Hong X, Miao W, Wang W, Wang C, Han R, Zhou J. Exploring prostate cancer incidence trends and age change in cancer registration areas of Jiangsu Province, China, 2009 to 2019. Curr Oncol. 2024, 31:5516-27. 10.3390\/curroncol31090408","journal-title":"Curr Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(18)30127-x","article-title":"Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries","volume":"17","author":"Zeng H","year":"2018","unstructured":"Zeng H, Chen W, Zheng R, et al.. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries.  Lancet. 2018, 17:555-67. 10.1016\/s2214-109x(18)30127-x","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2010.46","article-title":"Epidemiology and risk factors for kidney cancer","volume":"7","author":"Chow WH","year":"2010","unstructured":"Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol. 2010, 7:245-57. 10.1038\/nrurol.2010.46","journal-title":"Nat Rev Urol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: a systematic review of risk factors","volume":"84","author":"Jubber I","year":"2023","unstructured":"Jubber I, Ong S, Bukavina L, et al.. Epidemiology of bladder cancer in 2023: a systematic review of risk factors. Eur Urol. 2023, 84:176-90. 10.1016\/j.eururo.2023.03.029","journal-title":"Eur Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 update on prostate cancer epidemiology and risk factors-a systematic review","volume":"84","author":"Bergengren O","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K, et al.. 2022 update on prostate cancer epidemiology and risk factors-a systematic review. Eur Urol. 2023, 84:191-206. 10.1016\/j.eururo.2023.04.021","journal-title":"Eur Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(21)00045-0","article-title":"Epidemiology and determinants of obesity in China","volume":"9","author":"Pan XF","year":"2021","unstructured":"Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021, 9:373-92. 10.1016\/s2213-8587(21)00045-0","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(22)00227-4","article-title":"Tobacco smoking and risks of more than 470 diseases in China: a prospective cohort study","volume":"7","author":"Chan KH","year":"2022","unstructured":"Chan KH, Wright N, Xiao D, et al.. Tobacco smoking and risks of more than 470 diseases in China: a prospective cohort study. Lancet Public Health. 2022, 7:e1014-26. 10.1016\/S2468-2667(22)00227-4","journal-title":"Lancet Public Health"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01546-X","article-title":"The path to healthy ageing in China: a Peking University-Lancet Commission","volume":"400","author":"Chen X","year":"2022","unstructured":"Chen X, Giles J, Yao Y, et al.. The path to healthy ageing in China: a Peking University-Lancet Commission. Lancet. 2022, 400:1967-2006. 10.1016\/S0140-6736(22)01546-X","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","unstructured":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021. a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024, 403:2133-61. 10.1016\/S0140-6736(24)00757-8","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"8","author":"Kocarnik JM","year":"2022","unstructured":"Kocarnik JM, Compton K, Dean FE, et al.. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2022, 8:420-44. 10.1001\/jamaoncol.2021.6987","journal-title":"JAMA Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","unstructured":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021. a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024, 403:2162-203. 10.1016\/S0140-6736(24)00933-4","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30977-6","article-title":"Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","unstructured":"Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019. a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet. 2020, 396:1160-203. 10.1016\/S0140-6736(20)30977-6","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.scib.2024.06.017","article-title":"A comprehensive genetic variant reference for the Chinese population","volume":"69","author":"Jiang T","year":"2024","unstructured":"Jiang T, Guo H, Liu Y, et al.. A comprehensive genetic variant reference for the Chinese population. Sci Bull (Beijing). 2024, 69:3820-5. 10.1016\/j.scib.2024.06.017","journal-title":"Sci Bull (Beijing)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-88682-1","article-title":"A comparative analysis of global and Chinese trends in the burden of kidney cancer from 1990 to 2021","volume":"15","author":"Qiao Z","year":"2025","unstructured":"Qiao Z, Xiong J, Zhang S, Chen L, Wang J, Chen R. A comparative analysis of global and Chinese trends in the burden of kidney cancer from 1990 to 2021. Sci Rep. 2025, 15:4558. 10.1038\/s41598-025-88682-1","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2019.04.016","article-title":"Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China","volume":"172","author":"Liu X","year":"2019","unstructured":"Liu X, Yu C, Bi Y, Zhang ZJ. Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China. Public Health. 2019, 172:70-80. 10.1016\/j.puhe.2019.04.016","journal-title":"Public Health"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-022-00666-2","article-title":"Adjuvant therapy options in renal cell carcinoma - targeting the metastatic cascade","volume":"20","author":"Fitzgerald KN","year":"2023","unstructured":"Fitzgerald KN, Motzer RJ, Lee CH. Adjuvant therapy options in renal cell carcinoma - targeting the metastatic cascade. Nat Rev Urol. 2023, 20:179-93. 10.1038\/s41585-022-00666-2","journal-title":"Nat Rev Urol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran L","year":"2021","unstructured":"Tran L, Xiao JF, Agarwal N, Duex JE, Theodorescu D. Advances in bladder cancer biology and therapy. Nat Rev Cancer. 2021, 21:104-21. 10.1038\/s41568-020-00313-1","journal-title":"Nat Rev Cancer"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-024-00900-z","article-title":"Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer","volume":"22","author":"Bakht MK","year":"2025","unstructured":"Bakht MK, Beltran H. Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer. Nat Rev Urol. 2025, 22:26-45. 10.1038\/s41585-024-00900-z","journal-title":"Nat Rev Urol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(18)30432-6","article-title":"Trends in smoking prevalence and implication for chronic diseases in China: serial national cross-sectional surveys from 2003 to 2013","volume":"7","author":"Wang M","year":"2019","unstructured":"Wang M, Luo X, Xu S, et al.. Trends in smoking prevalence and implication for chronic diseases in China: serial national cross-sectional surveys from 2003 to 2013. Lancet Resp Med. 2019, 7:35-45. 10.1016\/s2213-2600(18)30432-6","journal-title":"Lancet Resp Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030452","article-title":"Androgen signaling in prostate cancer","volume":"7","author":"Dai C","year":"2017","unstructured":"Dai C, Heemers H, Sharifi N. Androgen signaling in prostate cancer. Cold Spring Harb Perspect Med. 2017, 7:10.1101\/cshperspect.a030452","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-02019-7","article-title":"Testosterone therapy and cancer risks among men in the SEER-Medicare\u00a0linked database","volume":"128","author":"Butler EN","year":"2023","unstructured":"Butler EN, Zhou CK, Curry M, et al.. Testosterone therapy and cancer risks among men in the SEER-Medicare\u00a0linked database. Br J Cancer. 2023, 128:48-56. 10.1038\/s41416-022-02019-7","journal-title":"Br J Cancer"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.37530","article-title":"Association of 13 occupational carcinogens in patients with cancer, individually and collectively, 1990-2017","volume":"4","author":"Li N","year":"2021","unstructured":"Li N, Zhai Z, Zheng Y, et al.. Association of 13 occupational carcinogens in patients with cancer, individually and collectively, 1990-2017. JAMA Netw Open. 2021, 4:e2037530. 10.1001\/jamanetworkopen.2020.37530","journal-title":"JAMA Netw Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/382495-the-temporal-trends-and-attributed-risk-burden-of-kidney-cancer-bladder-cancer-and-prostate-cancer-in-china-from-1990-to-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T11:55:23Z","timestamp":1752062123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/382495-the-temporal-trends-and-attributed-risk-burden-of-kidney-cancer-bladder-cancer-and-prostate-cancer-in-china-from-1990-to-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.87583","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,9]]}}}